Explore 3 Stock Ideas & Industry Insights Download Free Report
• RENX shares gained 1.09% on 1 July 2026, closing at 2.33 GBX
• LSE:CRW – Craneware plc delivered another strong FY2026 interim performance with 6% revenue growth, 10% adjusted EBITDA growth and 16% adjusted EPS growth.
• AstraZeneca PLC (LSE:AZN) remains one of the most closely watched FTSE 100 companies as investors continue to monitor its expanding pharmaceutical pipeline and global growth strategy.
Shares in the London-listed biopharma group climbed to feature among the UK market’s top gainers, drawing renewed attention to a name that operates at the intersection of neuroscience, immunology and the body’s own defence systems.
• GSK ranks among the UK's larger companies by market value, at roughly £79.45 billion.
• Scancell Holdings PLC (LSE:SCLP) featured among the UK's biggest stock fallers, with the shares recorded around 16.75p, down approximately 8.97%.
• Probiotix Health PLC (LSE:PBX) featured among the UK's biggest stock fallers, with the shares recorded around 7.510p, down approximately 3.10%.
• SkinBioTherapeutics PLC (LSE:SBTX) featured among the UK's biggest stock fallers, with the shares recorded around 11.25p, down approximately 8.16%.
• Inspiration Healthcare Group (LSE:IHC) featured among the UK's biggest stock fallers, with the shares recorded around 20.5p, down approximately 4.65%.
• MedPal AI PLC (LSE:MPAL) featured among the UK's biggest stock fallers, with the shares recorded around 4.450p, down approximately 3.26%.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…